Preoperative modified FOLFIRINOX (mFOLFIRINOX) followed by chemoradiation (CRT) for borderline resectable (BLR) pancreatic cancer (PDAC): Initial results from Alliance Trial A021101.
      Google Scholar   
Citation:
J Clin Oncol vol 33 (suppl) abstr 4008
Meeting Instance:
ASCO 2015
Year:
2015
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
2423  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, CA180888, CA180820  
Corr. Author:
 
Authors:
                                 
Networks:
CA136, CA249, CA824, GULFSOUTH, IL018, KY002, LAPS-IL057, LAPS-MN026, LAPS-NY016, LAPS-TN008, LAPS-TX035, LAPS-WI020, NORTHWELL, OH070   
Study
Alliance-A021101
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
N/A
Keywords: